Perspective Therapeutics CATX
NYSE CATX
$3.31 -0.17 (-5.03%)
At close: Aug 20, 2026 · 10:28 AM UTC

Perspective Therapeutics (CATX) EPS (Diluted) (2023 - 2026)

Perspective Therapeutics (CATX) EPS (Diluted) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Abbott Laboratories 199.54 Bn 193.94 Bn 7.27 Bn 0.53
2 Stryker 129.61 Bn 126.14 Bn 4.50 Bn 3.31
3 Medtronic 120.10 Bn 110.88 Bn 6.41 Bn 0.98
4 Boston Scientific 74.14 Bn 73.60 Bn 3.85 Bn 0.61
5 Edwards Lifesciences 52.52 Bn 48.27 Bn 1.35 Bn 0.42
6 Dexcom 34.69 Bn 32.75 Bn 830.00 Mn 0.64
7 GE HealthCare Technologies 33.78 Bn 31.68 Bn 2.18 Bn 1.26
8 Koninklijke Philips 26.42 Bn 23.10 Bn 4.55 Bn 0.64
9 Steris 23.09 Bn 22.61 Bn 684.20 Mn 2.05
10 Perspective Therapeutics 399.35 Mn 399.35 Mn - -0.22

Historic Data

Download Data
DateValue
Jun 30, 2026 0.00
Mar 31, 2026 -0.28
Jun 30, 2025 0.01
Jun 30, 2024 -0.01
Mar 31, 2024 -0.01
Dec 31, 2023 -0.19
Sep 30, 2023 -0.03
Jun 30, 2023 -0.06
Mar 31, 2023 -0.06